MATH, HPV status in HNSCC patients effective markers of improved patient outcome

(American Society for Radiation Oncology) Evaluating next-generation sequencing data and associated clinical records of head and neck squamous cell carcinoma patients from several institutions, made available through The Cancer Genome Atlas, showed that combining mutant-allele tumor heterogeneity as a biomarker with the patient's HPV status provides an effective indicator of improved patient outcome, according to research presented today at the 2014 Multidisciplinary Head and Neck Cancer Symposium.

http://www.eurekalert.org/pub_releases/2014-02/asfr-mhs021914.php

Source: EurekAlert! - Cancer - February 20, 2014 Category: Cancer & Oncology Source Type: news